TITLE

Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome

PUB. DATE
September 2008
SOURCE
Current Medical Literature: Lysosomal Storage Disease;2008, Vol. 8 Issue 2, p68
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the result of the study which assesses the effectiveness of enzyme replacement therapy (ERT) and hematopoietic stem cell transplantation (HSCT) in treating patients with mucopolysaccharidosis type I (MPS I) or Hurler syndrome. The study was participated by seven patients who underwent HSCT for 11-14 weeks and combination of both treatments for 8 weeks. It shows that both treatments reduced pulmonary diseases, morbidity, and promotes normal α-L-iduronidase level.
ACCESSION #
38696999

 

Related Articles

  • NICE recommends further research into sebelipase-α for LAL.  // PharmacoEconomics & Outcomes News;Feb2016, Vol. 747 Issue 1, p34 

    The article focuses on the recommendation of The National Institute forHealth and Care Excellence (NICE) for research of treatment for lysosomal acid lipase (LAL) deficiency with sebelipase-α (Kanuma) and stem cell transplantation, with short term and long term benefits and costs.

  • Overview of the mucopolysaccharidoses. Muenzer, Joseph // Rheumatology;Dec2011 Supplement 5, Vol. 50 Issue suppl_5, pv4 

    The mucopolysaccharidoses (MPSs) are a group of rare, inherited lysosomal storage disorders that are clinically characterized by abnormalities in multiple organ systems and reduced life expectancy. The MPSs are heterogeneous, progressive disorders. Patients typically appear normal at birth, but...

  • Stem Cell Therapies for the Lysosomal Storage Diseases -- the Quintessential Neurodegenerative Diseases. Schwartz, Philip Hitchins; Brick, David Joseph // Current Stem Cell Research & Therapy;May2008, Vol. 3 Issue 2, p88 

    As a novel neurotherapeutic strategy, stem cell transplantation has received considerable attention. However, little focus of this attention has been devoted to the probabilities of success of stem cell therapies for specific neurological disorders. Given the complexities of the cellular...

  • Mukopolysacharidóza I - klinické projevy u 24 dÄ•tí z ÄŒeské republiky a Slovenska. Ješina, P.; Magner, M.; Poupĕtová, H.; Honzíkova, J.; Dvořáková, L.; Malinová, V.; Hrubá, E.; Hlavatá, A.; Honzík, T.; Veselá, K.; Sedláček, P.; Starý, J.; Zeman, J. // Czecho-Slovak Pediatrics / Cesko-Slovenska Pediatrie;Jun2011, Vol. 66 Issue 4, p215 

    Mucopolysaccharidosis I (MPS I) is severe metabolic storage disease caused by impaired function of α-L-iduronidase. The aim of this study is to describe clinical symptoms, natural course and to evaluate results of treatment in Czech and Slovak children with MPS I. Methods: Study group...

  • Other Experimental Therapies in Neimann Pick Diseases. Mahdi, Mohammad // Iranian Journal of Child Neurology;2015 Supplement, Vol. 9, p25 

    An abstract of the article "Other Experimental Therapies in Neimann Pick Diseases" by Mohammad Mahdi Taghdiri, is presented.

  • Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure.  // Current Medical Literature: Lysosomal Storage Disease;2012, Vol. 10 Issue 1, p28 

    The article focuses on the study regarding the use of hematopoietic stem cell transplantation and enzyme replacement therapy (ERT) for the diagnosis of mucopolysaccharidosis type (MPS I) I patients. It states that MPS IH can in early death, usually within the first 20 years of life, if left...

  • Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure.  // Orphanet Journal of Rare Diseases;2011, Vol. 6 Issue 1, p55 

    The article presents a European consensus procedure which showed the use of enzyme replacement therapy (ERT) and hematopoietic stem cell transplantation (HSCT) in the treatment of patient having mucopolysaccharidosis type I (MPS I). In this procedure a panel of specialists developed...

  • Siblings with fucosidosis. Muthusamy, Karthik; Thomas, Maya Mary; George, Renu Elizabeth; Alexander, Mathew; Mani, Sunithi; Benjamin, Rohit N. // Journal of Pediatric Neurosciences;May-Aug2014, Vol. 9 Issue 2, p156 

    Fucosidosis is a rare lysosomal storage disorder due to deficiency of fucosidase enzyme, with around 100 cases reported worldwide. Here, we describe the clinical and imaging features in two siblings with fucosidosis. An 8-year-old girl presented with global developmental delay, followed by...

  • Breakthrough in Stem Cell Therapy.  // India -- West;7/16/2010, Vol. 25 Issue 34, pA41 

    The article reports on the success of an autologous stem cell-based therapy procedure in a nine-month-old dog conducted by researchers at Tamil Nadu Veterinary and Animal Sciences in India.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics